MedPath

Nicotine

Generic Name
Nicotine
Brand Names
Habitrol, Nicoderm C-Q, Nicorelief, Nicorette, Nicotrol
Drug Type
Small Molecule
Chemical Formula
C10H14N2
CAS Number
54-11-5
Unique Ingredient Identifier
6M3C89ZY6R

Overview

Nicotine is highly toxic alkaloid. It is the prototypical agonist at nicotinic cholinergic receptors where it dramatically stimulates neurons and ultimately blocks synaptic transmission. Nicotine is also important medically because of its presence in tobacco smoke.

Background

Nicotine is highly toxic alkaloid. It is the prototypical agonist at nicotinic cholinergic receptors where it dramatically stimulates neurons and ultimately blocks synaptic transmission. Nicotine is also important medically because of its presence in tobacco smoke.

Indication

For the relief of nicotine withdrawal symptoms and as an aid to smoking cessation.

Associated Conditions

  • Withdrawal Nicotine

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor
2025/06/05
Early Phase 1
Not yet recruiting
2025/04/16
Not Applicable
Recruiting
2025/02/06
Phase 3
Not yet recruiting
2025/01/08
Not Applicable
Recruiting
2024/12/20
Not Applicable
Completed
2024/09/19
Not Applicable
Completed
2024/09/19
Phase 4
Recruiting
2024/09/05
Not Applicable
Not yet recruiting
2024/08/15
Phase 3
Active, not recruiting
2024/08/09
Phase 4
Recruiting

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
H E B
37808-863
ORAL
2 mg in 1 1
5/19/2025
Blip Products, Inc.
82966-012
ORAL
2 mg in 1 1
3/17/2025
Dr. Reddy's Laboratories Inc.
43598-487
ORAL
4 mg in 1 1
6/23/2025
Meijer Distribution Inc
41250-424
ORAL
4 mg in 1 1
5/1/2025
H E B
37808-739
ORAL
4 mg in 1 1
5/15/2025
Topco Associates LLC
36800-269
ORAL
2 mg in 1 1
2/27/2025
Amazon.com Services LLC
72288-623
ORAL
2 mg in 1 1
5/2/2025
BJWC
68391-012
ORAL
2 mg in 1 1
3/17/2025
Walgreen Company
0363-7269
ORAL
2 mg in 1 1
2/27/2025
Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)
55910-976
ORAL
4 mg in 1 1
1/29/2025

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
NICORETTE QUICKMIST MOUTHSPRAY 1MG/SPRAY
SIN16567P
SPRAY
1mg/spray
8/8/2022
Nicorette Invisi Transdermal Patch 25mg/16 hours
SIN14296P
PATCH, EXTENDED RELEASE
39.37 mg/22.5 sq cm
1/17/2013
SKIIP NICOTINE MINI LOZENGE 2 MG (MINT)
SIN16895P
LOZENGE
2.00 mg
10/30/2023
NICOTINELL TTS 20 TRANSDERMAL THERAPEUTIC SYSTEM 14 mg/24 hrs
LTS LOHMANN THERAPIE-SYSTEME AG
SIN06527P
PATCH
35 mg/20 sq cm
11/12/1991
Nicorette Invisi Transdermal Patch 15mg/16 hours
SIN14295P
PATCH, EXTENDED RELEASE
23.62mg / 13.5 sq cm
1/17/2013
NICOTINELL TTS 10 TRANSDERMAL THERAPEUTIC SYSTEM 7 mg/24 hrs
LTS LOHMANN THERAPIE-SYSTEME AG
SIN06528P
PATCH
17.5 mg/10 sq cm
11/12/1991
SKIIP NICOTINE MINI LOZENGE 4 MG (MINT)
SIN16971P
LOZENGE
4.00 mg
3/13/2024
NICOTINELL MINT 4MG CHEWING GUM
FERTIN PHARMA A/S (7100)
SIN12570P
GUM, CHEWING
4 mg
7/27/2004
NICOTINELL TTS 30 TRANSDERMAL THERAPEUTIC SYSTEM 21 mg/24 hrs
LTS LOHMANN THERAPIE-SYSTEME AG
SIN06529P
PATCH
52.5 mg/30 sq cm
11/12/1991
Nicorette Icy Mint Medicated Chewing Gum 4mg
SIN14327P
GUM, CHEWING
4mg
3/12/2013

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
Nicotine Chewing Gum
国药准字HJ20160591
化学药品
咀嚼胶
9/7/2023
Nicotine Chewing Gum
国药准字HJ20160632
化学药品
咀嚼胶
9/7/2023
Nicotine Chewing Gum
国药准字HJ20160588
化学药品
咀嚼胶
9/7/2023
Nicotine Chewing Gum
国药准字HJ20160589
化学药品
咀嚼胶
9/7/2023
Nicotine Chewing Gum
国药准字HJ20160590
化学药品
咀嚼胶
9/7/2023
Nicotine Chewing Gum
国药准字HJ20160633
化学药品
咀嚼胶
9/7/2023
Nicotine Chewing Gum
国药准字J20170025
化学药品
咀嚼胶
4/24/2017
Nicotine Sublingual Tablets
国药准字H20041568
化学药品
片剂
11/27/2020
© Copyright 2025. All Rights Reserved by MedPath